{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:26Z","timestamp":1787440946218,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012496","name":"Lorestan University of Medical Sciences","doi-asserted-by":"publisher","award":["1397-1-99-2822"],"award-info":[{"award-number":["1397-1-99-2822"]}],"id":[{"id":"10.13039\/501100012496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119606","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:42:25Z","timestamp":1780929745000},"page":"119606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exosomal MALAT1 expression associated with the cardioprotective effects of carvacrol in acute doxorubicin-induced cardiac injury: Potential involvement of Nrf2\/Keap1-related signaling"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-5529","authenticated-orcid":false,"given":"Tooba","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajihe","family":"Ghorbanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Hosseinnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Zynivand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat","family":"Moradipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2477-9461","authenticated-orcid":false,"given":"Hassan","family":"Dariushnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119606_bib1","article-title":"LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119606_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring","volume":"96","author":"Wenningmann","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119606_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1621409","article-title":"Utilization of dexrazoxane in patients treated with doxorubicin: a retrospective, propensity matched analysis of cardiac function and toxicity","volume":"15","author":"Neiman","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119606_bib4","article-title":"Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings","author":"Asensio-Lopez","year":"2025","journal-title":"Front. Media SA"},{"issue":"4","key":"10.1016\/j.biopha.2026.119606_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell. death & Dis."},{"issue":"7","key":"10.1016\/j.biopha.2026.119606_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41419-022-05100-4","article-title":"Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85\u03b1","volume":"13","author":"Shen","year":"2022","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119606_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110469","article-title":"Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2\/Keap1 pathway","volume":"377","author":"Wang","year":"2023","journal-title":"Chem. - Biol. Interact."},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41420-023-01565-0","article-title":"Nrf2: a dark horse in doxorubicin-induced cardiotoxicity","volume":"9","author":"Zhao","year":"2023","journal-title":"Cell. death Discov."},{"key":"10.1016\/j.biopha.2026.119606_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157302","article-title":"Xin-Ji-Er-Kang modulates NRF2 to inhibit ferroptosis and attenuate doxorubicin-induced myocardial injury","author":"Yang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2026.119606_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2020.07.011","article-title":"Emerging crosstalk between long non-coding RNAs and Nrf2 signaling","volume":"490","author":"Bhattacharjee","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119606_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12012-017-9424-0","article-title":"Asiatic acid ameliorates doxorubicin-induced cardiac and hepato-renal toxicities with Nrf2 transcriptional factor activation in rats","volume":"18","author":"Kamble","year":"2018","journal-title":"Cardiovasc. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119606_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12265-020-10040-5","article-title":"Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology","volume":"14","author":"Henning","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119606_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/iub.2210","article-title":"The role of lncRNA MALAT1 in cardiovascular disease","volume":"72","author":"Yan","year":"2020","journal-title":"IUBMB life"},{"issue":"9","key":"10.1016\/j.biopha.2026.119606_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/ptr.6103","article-title":"Carvacrol and human health: a comprehensive review","volume":"32","author":"Sharifi-Rad","year":"2018","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119606_bib15","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/fsn3.2994","article-title":"Therapeutic application of carvacrol: a comprehensive review","volume":"10","author":"Imran","year":"2022","journal-title":"Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2026.119606_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.34172\/bma.28","article-title":"Carvacrol and paclitaxel: synergistic effect on apoptosis in breast cancer cell lines","volume":"2","author":"Dariushnejad","year":"2025","journal-title":"Biomed. Adv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jbt.21740","article-title":"Thymol and carvacrol prevent doxorubicin-induced cardiotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats","volume":"30","author":"El-Sayed","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep23978","article-title":"ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles","volume":"6","author":"Rider","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119606_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12033-021-00300-3","article-title":"Elucidating methods for isolation and quantification of exosomes: a review","volume":"63","author":"Kurian","year":"2021","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119606_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.811971","article-title":"Review on strategies and technologies for exosome isolation and purification","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"131","key":"10.1016\/j.biopha.2026.119606_bib21","first-page":"56482","article-title":"Sample preparation and imaging of exosomes by transmission electron microscopy","author":"Jung","year":"2018","journal-title":"J. Vis. Exp. JoVE"},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib22","article-title":"Stem cell-derived exosomes prevent aging-induced cardiac dysfunction through a novel exosome\/lncRNA MALAT1\/NF-\u03baB\/TNF-\u03b1 signaling pathway","volume":"2019","author":"Zhu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119606_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"methods"},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119606_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cvr\/cvs282","article-title":"Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes","volume":"96","author":"Kawaguchi","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2026.119606_bib26","doi-asserted-by":"crossref","unstructured":"Lv X., Yu X., Wang Y., Wang F., Li H., Wang Y., et al. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. 2012.","DOI":"10.1371\/journal.pone.0047351"},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib27","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41598-018-37862-3","article-title":"Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration","volume":"9","author":"Abdullah","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","article-title":"Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy","volume":"37","author":"Teichholz","year":"1976","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119606_bib29","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-019-1901-x","article-title":"miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity","volume":"10","author":"Pan","year":"2019","journal-title":"Cell. Death & Dis."},{"issue":"12","key":"10.1016\/j.biopha.2026.119606_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41419-022-05460-x","article-title":"FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM","volume":"13","author":"Bi","year":"2022","journal-title":"Cell. death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2026.119606_bib31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41419-018-0727-2","article-title":"Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity","volume":"9","author":"Guo","year":"2018","journal-title":"Cell. Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41420-022-01144-9","article-title":"Long noncoding RNA NONMMUT015745 inhibits doxorubicin-mediated cardiomyocyte apoptosis by regulating Rab2A-p53 axis","volume":"8","author":"Cai","year":"2022","journal-title":"Cell. Death Discov."},{"issue":"3","key":"10.1016\/j.biopha.2026.119606_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HCO.0000000000000617","article-title":"Adriamycin-associated cardiomyopathy: where are we now? updates in pathophysiology, dose recommendations, prognosis, and outcomes","volume":"34","author":"Hardaway","year":"2019","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.biopha.2026.119606_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101394","article-title":"Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: have we been barking up the wrong tree?","volume":"29","author":"Kalyanaraman","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119606_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110228","article-title":"Non-coding RNAs are involved in the response to oxidative stress","volume":"127","author":"Ghafouri-Fard","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.biopha.2026.119606_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41419-020-2508-y","article-title":"Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis","volume":"11","author":"Wu","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119606_bib37","series-title":"Exosomal RNA","first-page":"1","article-title":"Exosomal RNA-an introduction","author":"Saha","year":"2024"},{"issue":"9","key":"10.1016\/j.biopha.2026.119606_bib38","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.18632\/aging.103136","article-title":"Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a","volume":"12","author":"Xia","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cbin.10701","article-title":"Long non-coding RNA MALAT1 functions as a mediator in cardioprotective effects of fentanyl in myocardial ischemia-reperfusion injury","volume":"41","author":"Zhao","year":"2017","journal-title":"Cell. Biol. Int."},{"issue":"4","key":"10.1016\/j.biopha.2026.119606_bib40","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbrc.2017.12.105","article-title":"The long non-coding RNA MALAT1 activates Nrf2 signaling to protect human umbilical vein endothelial cells from hydrogen peroxide","volume":"495","author":"Zeng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119606_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41419-020-03318-8","article-title":"LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells","volume":"12","author":"Xiong","year":"2021","journal-title":"Cell. Death Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:52:46Z","timestamp":1787439166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0753332226006426"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119606","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal MALAT1 expression associated with the cardioprotective effects of carvacrol in acute doxorubicin-induced cardiac injury: Potential involvement of Nrf2\/Keap1-related signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119606"}}